APA
Doz F., Locatelli F., Baruchel A., Blin N., De Moerloose B., Frappaz D., Dworzak M., Fischer M., Stary J., Fuertig R., Riemann K., Taube T. & Reinhardt D. (20200205). Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors. : Pediatric blood & cancer.
Chicago
Doz François, Locatelli Franco, Baruchel André, Blin Nicolas, De Moerloose Barbara, Frappaz Didier, Dworzak Michael, Fischer Matthias, Stary Jan, Fuertig Rene, Riemann Kathrin, Taube Tillmann and Reinhardt Dirk. 20200205. Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors. : Pediatric blood & cancer.
Harvard
Doz F., Locatelli F., Baruchel A., Blin N., De Moerloose B., Frappaz D., Dworzak M., Fischer M., Stary J., Fuertig R., Riemann K., Taube T. and Reinhardt D. (20200205). Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors. : Pediatric blood & cancer.
MLA
Doz François, Locatelli Franco, Baruchel André, Blin Nicolas, De Moerloose Barbara, Frappaz Didier, Dworzak Michael, Fischer Matthias, Stary Jan, Fuertig Rene, Riemann Kathrin, Taube Tillmann and Reinhardt Dirk. Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors. : Pediatric blood & cancer. 20200205.